{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:11:59Z","timestamp":1785402719392,"version":"3.56.0"},"reference-count":42,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and Clinical Significance: Primary central nervous system (CNS) germinomas are rare intracranial germ cell tumors that predominantly affect children and young adults. Histopathological evaluation remains the diagnostic gold standard; however, molecular characterization has increasingly contributed to tumor classification and biological understanding. Recent advances in cerebrospinal fluid tumor-derived nucleic acid (CSF-tNA) analysis provide an opportunity to identify tumor-associated genomic alterations through minimally invasive testing; however, its ability to distinguish CNS germ cell tumor subtypes has not been established and it should be interpreted as a complementary rather than standalone diagnostic tool. Case Presentation: We report a patient with an intracranial mass whose histopathological examination demonstrated features consistent with germinoma. Immunohistochemistry confirmed the diagnosis. Concurrent CSF-tNA analysis using Summit\u2122 2.0 assay revealed a 12p gain encompassing KRAS, along with copy number gains of chromosome arms 21q and 1q and losses of chromosome arms 11q, 13q, 5q, and 9q. Although these alterations overlap with molecular profiles reported in CNS germ cell tumors, including recurrent 12p gain and RAS\/MAPK pathway activation, they cannot distinguish germinoma from other CNS germ cell tumor subtypes and should be interpreted in conjunction with histopathologic, radiographic, and clinical findings. Conclusions: This case illustrates the potential complementary role of CSF genomic profiling alongside conventional histopathology. CSF-based genomic analysis may contribute to supportive molecular information and may have future applications in disease monitoring rather than definitive tumor classification or subtype discrimination.<\/jats:p>","DOI":"10.3390\/diagnostics16152394","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:09:42Z","timestamp":1785398982000},"page":"2394","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal Fluid Genomic Profiling as an Adjunct in a Case of Intracranial Germinoma: Utility and Limitations"],"prefix":"10.3390","volume":"16","author":[{"given":"Edina","family":"Komlodi-Pasztor","sequence":"first","affiliation":[{"name":"MedStar Georgetown University Hospital, Washington, DC 20006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindhya","family":"Udhane","sequence":"additional","affiliation":[{"name":"Belay Diagnostics, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Watson","sequence":"additional","affiliation":[{"name":"MedStar Georgetown University Hospital, Washington, DC 20006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Sloan","sequence":"additional","affiliation":[{"name":"MedStar Georgetown University Hospital, Washington, DC 20006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9683-3802","authenticated-orcid":false,"given":"Anousheh","family":"Sayah","sequence":"additional","affiliation":[{"name":"MedStar Georgetown University Hospital, Washington, DC 20006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-3978","authenticated-orcid":false,"given":"Erini","family":"Makariou","sequence":"additional","affiliation":[{"name":"MedStar Georgetown University Hospital, Washington, DC 20006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Larson","sequence":"additional","affiliation":[{"name":"Belay Diagnostics, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-3908","authenticated-orcid":false,"given":"DeElegant","family":"Robinson","sequence":"additional","affiliation":[{"name":"Belay Diagnostics, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8061-0842","authenticated-orcid":false,"given":"Kala F.","family":"Schilter","sequence":"additional","affiliation":[{"name":"Belay Diagnostics, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Nie","sequence":"additional","affiliation":[{"name":"Belay Diagnostics, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-9993","authenticated-orcid":false,"given":"Honey V.","family":"Reddi","sequence":"additional","affiliation":[{"name":"Belay Diagnostics, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0883073818772470","article-title":"Central Nervous System Germ Cell Tumors: A Review of the Literature","volume":"33","author":"Kong","year":"2018","journal-title":"J. Child Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12032-013-0496-9","article-title":"Primary CNS germ cell tumors: Current epidemiology and update on treatment","volume":"30","author":"Thakkar","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MPH.0b013e3181983af5","article-title":"Incidence patterns of central nervous system germ cell tumors: A SEER Study","volume":"31","author":"Goodwin","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jfma.2024.05.016","article-title":"Prognostic implications of distinctive imaging characteristics in primary intracranial germ cell tumors: A retrospective analysis","volume":"124","author":"Wang","year":"2025","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Takami, H., and Ichimura, K. (2022). Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.982608"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/EB.S389631","article-title":"Diagnosis and Management of Pineal Germinoma: From Eye to Brain","volume":"15","author":"Cohen","year":"2023","journal-title":"Eye Brain"},{"key":"ref_7","first-page":"1719","article-title":"Primary Central Nervous System Germ Cell Tumors: A Review and Update","volume":"6","author":"Fetcko","year":"2018","journal-title":"Med. Res. Arch."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/neuonc\/not050","article-title":"Bifocal intracranial tumors of nongerminomatous germ cell etiology: Diagnostic and therapeutic implications","volume":"15","author":"Aizer","year":"2013","journal-title":"Neuro-Oncology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100860","DOI":"10.1016\/j.neo.2022.100860","article-title":"Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach","volume":"36","author":"Yeo","year":"2023","journal-title":"Neoplasia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/neuonc\/noab252","article-title":"EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","volume":"24","author":"Frappaz","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Liu, J., Yue, Q., Chen, L., Zhang, X., Lin, X., Zheng, L., Wang, E., Wang, Y., and Mao, Y. (2025). Optimal treatment approach for intracranial germinoma: A systematic review and meta-analysis. BMC Cancer, 25.","DOI":"10.1186\/s12885-024-13323-1"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Takami, H., Graffeo, C.S., Perry, A., Giannini, C., Nakazato, Y., Saito, N., Matsutani, M., Nishikawa, R., Ichimura, K., and Daniels, D.J. (2022). Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort. Cancers, 14.","DOI":"10.3390\/cancers14040979"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ilcus, C., Silaghi, H., Georgescu, C.E., Georgiu, C., Ciurea, A.I., Nicoara, S.D., and Silaghi, C.A. (2021). Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070661"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S1470-2045(15)00244-2","article-title":"Consensus on the management of intracranial germ-cell tumours","volume":"16","author":"Murray","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/neuonc\/nox122","article-title":"Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial","volume":"19","author":"Calaminus","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.wnl.0000261908.36803.ac","article-title":"CNS germ cell tumor (CNSGCT) of childhood: Presentation and delayed diagnosis","volume":"68","author":"Crawford","year":"2007","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jablonska, I., Golawski, M., Nowicka, E., Drosik-Rutowicz, K., Trybus, A., Tarnawski, R., and Miszczyk, M. (2023). Intracranial Germinoma-Association between Delayed Diagnosis, Altered Clinical Manifestations, and Prognosis. Cancers, 15.","DOI":"10.3390\/cancers15102789"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00381-013-2164-y","article-title":"Latency of intracranial germ cell tumors and diagnosis delay","volume":"29","author":"Phi","year":"2013","journal-title":"Childs Nerv. Syst."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Partenope, C., Pozzobon, G., Weber, G., Carceller, F., and Albanese, A. (2023). Implications of deferred diagnosis of paediatric intracranial germ cell tumours. Pediatr. Blood Cancer, 70.","DOI":"10.1002\/pbc.30168"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kopp, A., Westarp, P., Nowak, M., Briel, N., Mastall, M., Brzobohata, A., Schenk, R., Schmid, M., Rhun, E.L., and Moch, H. (2026). Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific mutations in patients with brain cancer using a widely available panel. Neurooncol. Adv., 8.","DOI":"10.1093\/noajnl\/vdaf270"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jmoldx.2025.05.011","article-title":"Cost-Effectiveness Analysis of Comprehensive Genomic Profiling in Patients with Advanced Non-Small-Cell Lung Cancer Using Real-World Data","volume":"27","author":"Spencer","year":"2025","journal-title":"J. Mol. Diagn."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"55026","DOI":"10.18632\/oncotarget.10392","article-title":"CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras\/Raf\/Erk- and Akt-pathways","volume":"7","author":"Schulte","year":"2016","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature13296","article-title":"Novel somatic and germline mutations in intracranial germ cell tumours","volume":"511","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)63120-3","article-title":"KIT mutations are common in testicular seminomas","volume":"164","author":"Kemmer","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00401-014-1247-5","article-title":"Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas","volume":"127","author":"Fukushima","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00401-016-1557-x","article-title":"Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy","volume":"131","author":"Ichimura","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jnen\/61.6.531","article-title":"Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors","volume":"61","author":"Okada","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Khurana, S., Keo, V., Larson, A., Udhane, V., Adams, J.N., Acevedo, A., Peltier, T., Sanchez, D., Domagala, B.A., and Vo, S.A. (2026). Analytical Validation and Clinical Sensitivity of the Belay Summit\u2122 2.0 Cerebrospinal Fluid Liquid Biopsy Test \u2014An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System Malignancies. Cancers, 18.","DOI":"10.3390\/cancers18020256"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nie, Q., Schilter, K.F., Larson, A., Udhane, V., Keo, V., Khurana, S., Adams, J.N., Acevedo, A., Sanchez, D., and Peltier, T. (2026). Clinical Validation of the Belay Ascent\u2122 Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome Sequencing. Cancers, 18.","DOI":"10.3390\/cancers18081277"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noab246","article-title":"12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors","volume":"24","author":"Satomi","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4143\/crt.2016.129","article-title":"Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005\u20132012","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/2019.11.JNS191576","article-title":"Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts","volume":"134","author":"Takami","year":"2021","journal-title":"J. Neurosurg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2176\/nmc.33.152","article-title":"Endocrine functions in children with suprasellar germinoma","volume":"33","author":"Aida","year":"1993","journal-title":"Neurol. Med.-Chir."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s12020-022-03121-9","article-title":"Endocrine manifestations of paediatric intracranial germ cell tumours: From diagnosis to long-term follow-up","volume":"77","author":"Partenope","year":"2022","journal-title":"Endocrine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-015-1809-y","article-title":"Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors","volume":"124","author":"Takami","year":"2015","journal-title":"J. Neurooncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/his.14560","article-title":"Primary mediastinal germ cell tumours: An immunohistochemical and molecular diagnostic approach","volume":"80","author":"Fichtner","year":"2022","journal-title":"Histopathology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00428-012-1353-5","article-title":"SALL4 is a useful marker in the diagnostic work-up of germ cell tumors in extra-testicular locations","volume":"462","author":"Camparo","year":"2013","journal-title":"Virchows Arch."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3171\/jns.1997.87.2.0262","article-title":"Management of primary intracranial germinomas: Diagnostic surgery or radical resection?","volume":"87","author":"Sawamura","year":"1997","journal-title":"J. Neurosurg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16967","article-title":"Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities","volume":"531","author":"Kerr","year":"2016","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pbc.24833","article-title":"Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors","volume":"61","author":"Terashima","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhou, J., Wu, C., and Li, S. (2024). CNS Germ Cell Tumors: Molecular Advances, Significance in Risk Stratification and Future Directions. Brain Sci., 14.","DOI":"10.3390\/brainsci14050445"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/neuonc\/noz139","article-title":"Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium","volume":"21","author":"Takami","year":"2019","journal-title":"Neuro-Oncology"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/15\/2394\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:28:51Z","timestamp":1785400131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/15\/2394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":42,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["diagnostics16152394"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16152394","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}